dc.contributor.author |
Bobomuratov T.A ., Karimova N.A., Tursunbaev A.K., Bakirova M.A |
|
dc.date.accessioned |
2023-02-02T10:25:56Z |
|
dc.date.available |
2023-02-02T10:25:56Z |
|
dc.date.issued |
2023 |
|
dc.identifier.uri |
http://repository.tma.uz/xmlui/handle/1/6243 |
|
dc.description.abstract |
COVID-19 (from the English Coronavirus disease 2019) is a new epidemic infectious disease characterized by a relatively high contagiousness and the likelihood of developing life-threatening complications in the form of acute respiratory distress syndrome, acute respiratory and multiple organ failure. a retrospective analysis of the incidence, clinical course and treatment of children with COVID-19 who were treated in a specialized hospital for the treatment of patients with coronavirus infection. We conducted a retrospective analysis of the case histories of 86 children of various ages who were hospitalized with a confirmed diagnosis of a new coronavirus infection COVID-19 in September-November 2020. There were 51 (%) boys, 34 (%) girls. Depending on age, patients were divided into 4 groups: up to 1 year - 7 (%), from 1 year to 6 years - 27 (%), from 7 to 12 years - 26 (%) and over 12 years - 26 (% ). Studies have shown that children with mild COVID-19 were treated on an outpatient basis and therefore were not included in the surveyed group. Children with moderate and severe forms of COVID-19 received inpatient treatment, and in our study, patients with moderate course - 57 (66.3%), and a severe course was noted in 29 (33.7%) children. |
en_US |
dc.language.iso |
en_US |
en_US |
dc.publisher |
Texas Journal of Medical Science |
en_US |
dc.subject |
COVID-19, children, cardiovascular system, myocardial damage, diagnosis |
en_US |
dc.title |
New Coronavirus Infection |
en_US |
dc.type |
Article |
en_US |